Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2013: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2012: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Outline of Final Research Achievements |
Induced pluripotent stem cells are a promising tool for regenerative medicine of muscular dystrophies. Here, we compared the cell surface antigens on human myoblasts and human fibroblasts, and found that CD56 and CD271 specifically recognize human myoblasts. Next, we tested whether EZ-sphere method is effective to induce transplantable muscle stem/progenitor cells by transplantation into immunodeficient mdx mice (DMD model mice) and found that iPS-derived muscle stem/progenitor cells participate in muscle regeneration.
|